Stay updated with the latest pfizer news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on pfizer topics.
New Delhi, Dec 17 (PTI) AI and technology solutions company UST has inked an initial agreement with the IIT Madras Incubation Cell (IITMIC) to promote innovation, entrepreneurship, and research-driven solutions in the healthcare and life sciences sectors. According to a release, the Memorandum of Understanding (MoU) aims to create a collaborative framework between UST and IITMIC (IIT Madras Incubation Cell, a deep-tech startup hub anchored at IIT Madras) to drive innovation through joint progra ...Read More >
Pfizer issued its 2026 guidance, expecting its adjusted earnings per share to come in below this year's figures, and revised its 2025 revenue outlook. The company reiterated its 2025 adjusted earnings guidance of $3 to $3.15 a share. It guided for 2025 revenue of $62 billion, compared with its previous forecast of $61 billion to $64 billion. Analysts see adjusted earnings of $3.13 a share and revenue of $62.5 billion, according to FactSet. Pfizer expects 2026 revenue of $59.5 billion to $62.5 ...Read More >
While India continues to attract record levels of foreign investment and corporate expansion, Pakistan has witnessed a steady retreat of global firms... While India continues to attract record levels of foreign investment and corporate expansion, Pakistan has witnessed a steady retreat of global firms across sectors. This contrast reflects not only macroeconomic trends but also the underlying business culture, regulatory frameworks, and institutional capacity that shape investor confidence and ...Read More >
Bengaluru - Global companies have flagged more than US$35 billion (S$45 billion) in costs from US tariffs heading into third-quarter earnings, but many are lowering their initial forecasts as new trade deals reduce exposure to President Donald Trump's levies. Mr Trump's trade war has hiked US tariffs to their highest levels since the 1930s, and the president has regularly threatened more duties, but overall, the fog that paralysed many businesses is clearing, allowing executives to forecast cos ...Read More >
New Delhi: The Delhi government will soon begin clearing pending electric vehicle (EV) subsidy dues amounting to about ₹140 crore, officials said on Monday as per PTI. Transport Minister Pankaj Singh confirmed that the department will verify all subsidy applications to resolve the backlog, which has piled up over the past two years. "The process of identifying eligible beneficiaries has already started," an official said. A dedicated portal for clearing dues is also being prepared. The develop ...Read More >
Hyderabad: A stunning revelation has rocked Hyderabad as police uncovered a covert alprazolam manufacturing unit operating inside Medha School, Bowenpally, in an operation led by the Elite Action Group for Drug Law Enforcement (EAGLE). Authorities seized over 7 kg of alprazolam, including 3.5 kg of finished product and 4.3 kg of semi-processed tablets, alongside raw materials and state-of-the-art manufacturing equipment. Along with the drugs, cash amounting to 21 lakh was recovered from the scho ...Read More >
Indian stock market: The equity market benchmark indices, Sensex and Nifty 50, are expected to open lower on Monday, following mixed cues from global markets. Asian markets traded mostly higher, while the US markets ended mixed, with the Nasdaq posting a record high close. This week, investors will focus on key stock market triggers, including the developments over India-US trade deal, US Federal Reserve policy, India-EU trade deal, flow of foreign funds, and other key domestic and macroeconom ...Read More >
Mumbai, Sep 13 (SocialNews.XYZ) Shares of US pharma giants fell over 3 per cent following reports indicating that the US health administration officials intend to associate coronavirus vaccines with the deaths of 25 children. Pfizer's stock declined by over 3 per cent, Moderna's fell by more than 7 per cent, and Novavax decreased by more than 4 per cent overnight. The selloff occurred after reports indicated that the claim will be presented next week to the US Centers for Disease Control and P ...Read More >
PRNewswire Mumbai (Maharashtra) [India], August 14: Medulla Communications Pvt. Ltd., one of the world's most awarded healthcare-specialist advertising agencies, has announced the launch of its new hub in Singapore. With over 15 years of experience in solving complex healthcare challenges, Medulla is now looking to create a super-specialist category as the first digital healthcare advertising agency in Asia. New Hub to Deliver Scalable, Specialist Healthcare Marketing Solutions Across APAC. Me ...Read More >
Mumbai (Maharashtra) [India], August 14: Medulla Communications Pvt. Ltd., one of the world's most awarded healthcare-specialist advertising agencies, has announced the launch of its new hub in Singapore. With over 15 years of experience in solving complex healthcare challenges, Medulla is now looking to create a super-specialist category as the first digital healthcare advertising agency in Asia. New Hub to Deliver Scalable, Specialist Healthcare Marketing Solutions Across APAC. Also Read | Ne ...Read More >
Sales reported at Rs -1.02 croreNet Loss of Microse India reported to Rs 1.48 crore in the quarter ended June 2025 as against net loss of Rs 0.03 crore during the previous quarter ended June 2024. Sales reported to Rs -1.02 crore in the quarter ended June 2025. There were no Sales reported during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales-1.020 0 OPM %145.100 -PBDT-1.48-0.03 -4833 PBT-1.48-0.03 -4833 NP-1.48-0.03 -4833 Powered by Capital Market ...Read More >
NEW YORK, Aug 5 (Reuters) - U.S. stocks ended lower on Tuesday as investors weighed the impact of tariffs after Yum Brands (YUM.N), opens new tab and other companies cited trade duties in their results or outlooks. In addition, U.S. President Donald Trump said the U.S. could impose a "small tariff" on pharmaceutical imports before increasing the rate subsequently. He also signaled an announcement on tariffs on semiconductors and chips in the "next week or so." Shares of KFC parent Yum Brands ( ...Read More >
Pithoragarh (Uttarakhand) [India], July 15 (ANI): Eight people were killed after a vehicle carrying 13 passengers met with an accident near the Suni bridge in Muwani town of Uttarakhand Pithoragarh district, a police officer said on Tuesday. Pithoragarh Superintendent of Police (SP) Rekha Yadav confirmed the incident and stated that a rescue operation is currently underway. Eight people died after a vehicle carrying 13 people crashed near the Suni bridge in Muwani town. The police officials ha ...Read More >
Hyderabad, July 15 (Maxim News): In a major boost for global healthcare access, Hyderabad-based Aurobindo Pharma has announced that it will manufacture and distribute the long-acting injectable HIV treatment drug, cabotegravir (CAB LA), across 133 countries. The development comes under an expanded voluntary licensing agreement between the Medicines Patent Pool (MPP) and ViiV Healthcare. This strategic agreement will allow Aurobindo to supply CAB LA for both prevention and treatment of HIV, offe ...Read More >
New Delhi: Pfizer Ltd has reported an 85 per cent jump in net profit at Rs 330.94 crore in the fourth quarter ended March 2025, boosted by a gain in exceptional item from completion of asset sale and transfer. The company had posted a net profit of Rs 178.86 crore in the corresponding quarter of preceding fiscal, Pfizer Ltd said in a regulatory filing. Revenue from operations in the quarter under review stood at Rs 591.91 crore as against Rs 546.63 crore in the year-ago period, it added. Tota ...Read More >
AstraZeneca is benefiting from surging demand for cancer treatments like Imfinzi and Calquence, and has a robust pipeline expected to deliver two dozen new products by 2030. Leading vaccine makers like Eli Lilly (NYSE:LLY), Pfizer (NYSE:PFE), and AstraZeneca NASDAQ:AZN) may have faded from the spotlight since the peak of the COVID-19 pandemic, but now there is reason to expect renewed interest. As investors look ahead to the second Trump administration, the incoming president's nomination of ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.